CausalSentinel

Protein Dossier — CCL2 (C-C motif chemokine 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.194 0.0561 5.62e-04 Wald ratio 1 trans NA
Ulcerative colitis -0.248 0.0775 0.00139 Wald ratio 1 trans NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone 0.363 0.122 0.00297 Wald ratio 1 trans NA
Inflammatory bowel disease -0.172 0.0615 0.00527 Wald ratio 1 trans NA
Weight 0.035 0.0135 0.00943 Wald ratio 1 trans NA
Amygdala volume 35.6 13.8 0.00959 Wald ratio 1 trans NA
Sodium in urine -0.0376 0.015 0.0123 Wald ratio 1 trans NA
Diagnoses - main ICD10: Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 0.234 0.0995 0.0187 Wald ratio 1 trans NA
Diagnoses - main ICD10: G56 Mononeuropathies of upper limb 0.204 0.0957 0.0335 Wald ratio 1 trans NA
Invasive mucinous ovarian cancer 0.483 0.229 0.0344 Wald ratio 1 trans NA
Diastolic blood pressure automated reading 0.0315 0.0156 0.0435 Wald ratio 1 trans NA
Diagnoses - main ICD10: K20 Oesophagitis 0.233 0.124 0.0604 Wald ratio 1 trans NA
…and 71 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2578_67_2 MCP-1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

72 association rows across 39 traits (69 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating CCL8 levels (id: OID00549_OID21466) 1e-346 rs11652585 5 GCST90859899 no MR -> candidate analysis
CCL7 protein levels 6e-281 rs74832623 2 GCST90428425 no MR -> candidate analysis
Circulating CCL8 levels (id: OID00795_OID21466) 8e-255 rs11652585 5 GCST90860127 no MR -> candidate analysis
Circulating CCL13 levels (id: OID00504_OID20655) 3e-208 rs6505402 1 GCST90859860 no MR -> candidate analysis
Circulating CCL13 levels (id: OID00768_OID20655) 4e-147 rs6505402 1 GCST90860103 no MR -> candidate analysis
C-C motif chemokine 7 levels 5e-62 rs12601658 5 GCST90246921 no MR -> candidate analysis
Corneodesmosin levels 1e-56 rs6505402 1 GCST90247131 no MR -> candidate analysis
Circulating CCL7 levels (id: OID00474_OID20523) 2e-48 rs6505401 2 GCST90859834 no MR -> candidate analysis
Serum levels of protein CCL7 4e-41 rs12601658 1 GCST90088794 no MR -> candidate analysis
Circulating CCL7 levels (id: OID00755_OID20523) 8e-34 rs6505401 2 GCST90860091 no MR -> candidate analysis
Circulating CCL11 levels (id: OID00505_OID20668) 1e-28 rs8080790 1 GCST90859861 no MR -> candidate analysis
Inflammatory bowel disease 1e-26 rs3091316 5 GCST001725 MR: beta=-0.172, p=0.00527 (trans)
…and 27 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2231 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Crohn disease 0.592 common-variant locus no MR -> candidate analysis
alcohol drinking 0.587 common-variant locus no MR -> candidate analysis
inflammatory bowel disease 0.506 common-variant locus MR: beta=-0.172, p=0.00527 (trans)
Abnormality of the skeletal system 0.509 common-variant locus no MR -> candidate analysis
ulcerative colitis 0.488 common-variant locus MR: beta=-0.248, p=0.00139 (trans)
urolithiasis 0.463 common-variant locus no MR -> candidate analysis
cartilage disease 0.456 common-variant locus no MR -> candidate analysis
colitis 0.41 common-variant locus MR: beta=-0.248, p=0.00139 (trans)
psoriasis 0.399 common-variant locus MR: beta=-0.252, p=0.192 (trans)
enteritis 0.41 common-variant locus no MR -> candidate analysis
B-cell acute lymphoblastic leukemia 0.412 common-variant locus no MR -> candidate analysis
ankylosing spondylitis 0.399 common-variant locus no MR -> candidate analysis
sclerosing cholangitis 0.399 common-variant locus MR: beta=-0.193, p=0.281 (trans)
nervous system benign neoplasm 0.375 common-variant locus no MR -> candidate analysis
drug allergy 0.367 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (C-C motif chemokine 2)
gnomAD constraint pLI=0.54, LOEUF=0.944 — LoF-tolerant
GWAS Catalog 101 unique SNPs / 210 rows
ClinVar 30 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance